• August 28, 2012
  • global.itsupport

Sproxil and Airtel Partner to Combat Drug Counterfeiting

Bharti Airtel, (‘Airtel’), a leading global telecommunications company with operations in 17 countries across Africa today announced a partnership with Sproxil to combat the counterfeit drug market in Africa. Sproxil’s

  • August 22, 2012
  • global.itsupport

Combat Counterfeit Goods – Sproxil

via Securing Pharma.The United Nation Office on Drugs and Crime (UNODC) recently launched a public awareness campaign to combat counterfeit goods. Counterfeit goods pose a serious risk to the health

  • July 24, 2012
  • global.itsupport

Sproxil’s MPA(TM) Solution Surpasses 2-Million Mark

Sproxil(R) Mobile Product Authentication™ Solution Surpasses 2 Million Usage Mark  Usage Rates Surge as Consumers Increasingly Adopt Texting Service in Battle Against Counterfeit Drugs Cambridge, MA (July 24, 2012) — Sproxil(R),

  • May 11, 2012
  • global.itsupport

Mangesh Hirve Joins Sproxil’s Advisory Board

Sproxil is pleased to announce that Mangesh Hirve has joined the Sproxil Advisory Board. Mangesh is a Product Director at an Upstream Exploration and Product Information company. Prior to joining

  • April 19, 2012
  • global.itsupport

East Africa losing money to counterfeiters

In a recent article, Mr. Omar Issa, CEO of Investment Climate Facility for Africa states that member states of the East African Community last year lost $500 million in taxes

  • April 4, 2012
  • global.itsupport

Cancer med found in U.S. found to be counterfeit!

Via the FDA:”FDA lab tests have confirmed that a counterfeit version of Roche’s Altuzan 400mg/16ml (bevacizumab),an injectable cancer medication, found in the U.S. contains no active ingredient. Even if the